Systems Investigation of Vaccine Responses in Aging and Frailty
Key claim: A systems biology study will compare the immunologic, transcriptomic, and metabolomic response signatures of two standard senior influenza vaccines (Fluad and Fluzone High-Dose) in adults aged 65 and older.
Abstract
This study will compare the immune response signatures (including immunologic, transcriptomic and metabolomic) of the two influenza vaccines approved for use in adults age 65 and over (Fluad and Fluzone High-Dose).
Why this matters
A systems biology study will compare the immunologic, transcriptomic, and metabolomic response signatures of two standard senior influenza vaccines (Fluad and Fluzone High-Dose) in adults aged 65 and older.